|
May 5
|
TG Therapeutics: Q1 Earnings Snapshot
|
|
May 5
|
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
|
|
Apr 17
|
Exploring US High Growth Tech Stocks
|
|
Mar 3
|
Meta, Netflix Test These Upper Limits As Tesla Exits The Scene While This Biotech Booms
|
|
Mar 3
|
TG Therapeutics Soars Nearly 18% as Strong Q4 Results Fuel Growth Optimism
|
|
Mar 3
|
TG Therapeutics (NasdaqCM:TGTX) Reports US$108M Revenue For Q4 2024 With Net Income Of US$23M
|
|
Mar 3
|
TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide
|
|
Mar 3
|
TG Therapeutics: Q4 Earnings Snapshot
|
|
Mar 3
|
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 27
|
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
|
|
Feb 26
|
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
|
|
Feb 25
|
Institutional investors in TG Therapeutics, Inc. (NASDAQ:TGTX) see US$243m decrease in market cap last week, although long-term gains have benefitted them.
|
|
Sep 5
|
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
|
|
Aug 30
|
TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory
|
|
Aug 12
|
FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
|
|
Aug 9
|
Results: TG Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit
|
|
Jul 30
|
TG Therapeutics, Inc.'s (NASDAQ:TGTX) recent 3.1% pullback adds to one-year year losses, institutional owners may take drastic measures
|
|
Jun 26
|
Stocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area
|
|
Jun 21
|
Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)
|
|
May 3
|
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript
|